Tiacumicin B Fermentation Medium Stabilization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current fermentation methods for producing tiacumicin B face challenges such as degradation of the molecule during fermentation, leading to reduced productivity and the need for lengthy and expensive purification processes due to unfavorable environmental conditions like pH variation and enzyme activity.
Innovation Solution
Incorporating emulsifiers and/or antifoaming agents, optionally with vegetable oils, into the fermentation medium to enhance tiacumicin B production and prevent degradation, thereby stabilizing the molecule and increasing productivity up to 10 times compared to basic media.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If fermentation is carried out in basic nutrient medium, then tiacumicin B is produced, but the molecule degrades due to unfavorable environmental conditions
Solution Approach 1:
The patent modifies the fermentation medium by adjusting pH to remain between 6.5-7.5 throughout the process, and by controlling redox potential and adding specific nutrients, to create optimal conditions that simultaneously enhance tiacumicin B production and prevent degradation
Solution Approach 2:
The patent introduces adsorbent resins (such as XAD-16, XAD-4, or XAD-7) as intermediary substances that selectively adsorb tiacumicin B from the fermentation broth, protecting it from degradation while allowing continuous production. The resin acts as a mediator between the antibiotic and the fermentation environment
2Productivity
If fermentation time is extended to increase production, then more tiacumicin B is formed, but degradation products accumulate
Solution Approach 1:
Adsorbent resins are introduced as intermediary substances that selectively adsorb tiacumicin B from the fermentation broth, protecting it from degradation while allowing continuous production. The resin acts as a mediator between the antibiotic and the fermentation environment
Solution Approach 2:
The patent implements continuous or fed-batch fermentation with periodic addition of substrates and removal of products via adsorption, maintaining optimal conditions throughout extended fermentation periods to prevent degradation while maximizing yield
3Adaptability or versatility
If pH variation is allowed in fermentation medium, then metabolic flexibility is maintained, but tiacumicin B degrades
Solution Approach 1:
The patent modifies the fermentation medium by adjusting pH to remain between 6.5-7.5 throughout the process, and by controlling redox potential and adding specific nutrients, to create optimal conditions that simultaneously enhance tiacumicin B production and prevent degradation
Solution Approach 2:
The patent employs pH and redox potential monitoring with automated feedback control systems that adjust acid/base addition and aeration rates to maintain optimal conditions, balancing metabolic flexibility with product stability
Data Source
AI summary
The present invention relates to a procedure for the production of tiacumicin B comprising fermentation of a micro-organism capable of producing tiacumicin B, in particular of the species Dactylosporangium aurantiacum or Actinoplanes deccanensis, in a culture broth containing emulsifiers, such as ethoxylated castor oil, in combination with antifoaming products and vegetable oils.